Correction to: Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab (Annals of Hematology, (2020), 99, 7, (1493-1503), 10.1007/s00277-020-04133-z)

Research output: Contribution to journalComment/debatepeer-review

Abstract

The original version of this article inadvertently contained a typographical error in the Abstract section. In the Abstract, the p-value demonstrating the statistically significant difference between the transfusion-independence rate for the eculizumab-treated group and the eculizumab-untreated group should be p = 0.0078, and not p = 0.078. The correct p-value (p = 0.0078) has been mentioned in the main text of the manuscript, and the error is only in the Abstract section. The original article has been correction.

Original languageEnglish
Pages (from-to)3083
Number of pages1
JournalAnnals of Hematology
Volume100
Issue number12
DOIs
Publication statusPublished - 2021 Dec

Bibliographical note

Publisher Copyright:
© Springer-Verlag GmbH Germany, part of Springer Nature 2021.

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Correction to: Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab (Annals of Hematology, (2020), 99, 7, (1493-1503), 10.1007/s00277-020-04133-z)'. Together they form a unique fingerprint.

Cite this